Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129,337,627
-
Total 13F shares
-
1,579,871
-
Share change
-
+841,585
-
Total reported value
-
$1,500,720
-
Put/Call ratio
-
45%
-
Price per share
-
$0.95
-
Number of holders
-
12
-
Value change
-
+$453,590
-
Number of buys
-
5
-
Number of sells
-
11
Institutional Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q4 2020
As of 31 Dec 2020,
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,579,871 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, Federation des caisses Desjardins du Quebec, BARCLAYS PLC, TWO SIGMA ADVISERS, LP, and NORTHERN TRUST CORP.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.